Company

Science with Purpose

We believe in people, long-term partnerships, and innovations that create lasting value as they evolve.

Our Promise

Elevate the standard of cancer care to help improve outcomes for all patients worldwide.

Our Focus

Apply advanced science and mathematics to the benefit of healthcare providers and oncology patients everywhere.

Our Mission

Expand access to global best practices, helping every healthcare system deliver higher-quality cancer care more consistently.

Science Led.
Human Focused.
Future Forward.

Excellence in Innovation

Global AI Leadership

TheraPanacea was founded on a simple but ambitious belief: the most complex problems in cancer care cannot be solved by human effort alone. They require advanced mathematics, deep scientific expertise, and long-term clinical collaboration.

2017
TheraPanacea founded as a spin-off of Paris-Saclay University
2019
ART-Plan receives CE and FDA approval for commercial use in OAR delineation
2021
Global expansion to 5 continents
2025
AI for RT planning and adaptive introduced
5

continents

300

clinical sites

~1K

years of clinical time saved

75+

employees

35%

PhDs

45%

females

23

nationalities

Leadership Team

Nikos Paragios, CEO & Founder, TheraPanacea
Nikos Paragios

CEO & Founder

Nikos Paragios

CEO & Founder

After a brilliant academic career, Nikos used his scientific training and research to solve a major societal problem, cancer, leading to the formation of TheraPanacea, where the latest scientific advances in artificial intelligence, mathematics and computer science have a considerable positive impact on cancer patients worldwide.

Steve Andersen, Chief Revenue Officer & GM United States, TheraPanacea
Steve Andersen

Chief Revenue Officer & GM United States

Steve Andersen

Chief Revenue Officer & GM United States

A versatile business executive with 20+ years of experience, Steve has delivered clinical, AI, and data management software solutions across healthcare. He leads change, builds high-performing teams, and drives growth through strong GTM strategy, customer success, global expansion, and strategic partnerships, fostering collaboration, trust, and organizational excellence.

Fabien Bellanger, Engineering Director, TheraPanacea
Fabien Bellanger

Engineering Director

Fabien Bellanger

Engineering Director

A technical and product leader with 30 years of experience, Fabien thrives on building from scratch. He rapidly masters new domains and transforms organizations with strategic vision, Agile expertise, and disciplined execution. Currently at TheraPanacea, he scales teams, shapes product direction, and drives innovation in a fast-growing startup environment.

Abhi Chakrabarti, Product & Marketing Director, TheraPanacea
Abhi Chakrabarti

Product & Marketing Director

Abhi Chakrabarti

Product & Marketing Director

A champion of common sense & plain language, Abhi is a seasoned product and marketing leader in healthcare AI. With a PhD in engineering and leadership roles across Elekta, Philips, and Voximetry, he drives innovation, commercialization, and global growth in advanced oncology solutions.

Alexandre Favre, Chief Financial Officer, TheraPanacea
Alexandre Favre

Chief Financial Officer

Alexandre Favre

Chief Financial Officer

Alexandre brings more than 20 years of international finance and leadership experience, including senior roles at Sanofi, combining deep expertise in healthcare, corporate finance, and business transformation to support TheraPanacea’s global growth and mission to advance AI-driven precision medicine.

Marta Le Berthe, Culture & HR Director, TheraPanacea
Marta Le Berthe

Culture & HR Director

Marta Le Berthe

Culture & HR Director

Marta is an experienced HR professional specializing in organizational development, change management, and strategic workforce planning. She partners with leadership teams to build strong, collaborative cultures, enhance team performance, and align HR strategy with business goals. Her expertise spans coaching, talent development, and driving impactful organizational transformation.

Catherine Martineau-Huynh, Chief Strategic Alliances Officer, TheraPanacea
Catherine Martineau-Huynh

Chief Strategic Alliances Officer

Catherine Martineau-Huynh

Chief Strategic Alliances Officer

A seasoned executive and co-founder, Catherine drives development of AI-powered solutions for cancer care. With a background spanning engineering, academia, and global transformation roles, she has led initiatives across Europe and Asia, combining strategic leadership, operational excellence, and deep expertise in healthcare innovation and organizational change.

Jean-Marc Peyrat, Science & Innovation Director, TheraPanacea
Jean-Marc Peyrat

Science & Innovation Director

Jean-Marc Peyrat

Science & Innovation Director

With 20+ years of experience in MedTech & AI, Jean-Marc brings his entrepreneurial passion to drive innovation at TheraPanacea. His expertise in medical imaging, cardiology, digital twins, and AI combines to help shape and deliver the transformative vision for TheraPanacea's AI platform, powering a new era of oncology.

Our Values

Excellence

Quality
Rigor
Performance

Setting the highest standards of AI integrity, scientific research, and clinical outcomes

People-Focus

Fairness
Collaboration
Trust

Ensuring AI complements human expertise, keeping people at the heart of everything we do

Innovation

Curiosity
Efficiency
Agility

Pushing the boundaries of technology, transforming cutting-edge discoveries into real-world solutions

Impact

Purpose
Results
Value

Delivering immediate clinical impact in radiotherapy while advancing long-term solutions for the future of oncology.

Commitment

Ownership
Integrity
Accountability

Dedicated to advancing oncology with expert-driven solutions that clinicians can trust

Our Values: Interview

Play Video

Join a team using science and AI to advance radiotherapy and cancer care.

Explore Careers

Contact Us

Message Successfully Sent

Thank you for your submission.